V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20010561 | 20004526 | 1.67 | 60.3 | Neo-adjuvant (N) | 2016-08-30 | 2016-09-16 | FEC 60 or 75 | N | N | 20037150 | FEC |
| 20010565 | 20004528 | 1.51 | 93.6 | Adjuvant (A) | 2017-07-24 | 2017-07-29 | FEC 60 or 75 | N | N | 20037157 | FEC |
| 20010566 | 20004528 | 1.58 | 68.2 | Adjuvant (A) | 2014-06-10 | 2014-07-01 | FEC 60 or 75 | N | N | 20037157 | FEC |
| 20010567 | 20004528 | 1.61 | 107.9 | Adjuvant (A) | 2018-01-16 | 2018-01-17 | FEC 100 | N | N | 20037157 | FEC |
| 20010568 | 20004529 | null | 64.2 | Adjuvant (A) | 2013-07-04 | 2013-08-05 | FEC 100 | N | N | 20037173 | FEC |
| 20010569 | 20004529 | null | 83.5 | Adjuvant (A) | 2017-02-17 | 2017-02-22 | FEC 100 | 99 | null | 20037173 | FEC |
| 20010570 | 20004530 | 1.65 | null | Curative (C) | 2014-11-27 | 2014-12-22 | FEC 100 | N | N | 20037176 | FEC |
| 20010571 | 20004530 | 1.66 | 83 | Curative (C) | 2015-08-02 | 2015-08-18 | FEC 100 | 02 | N | 20037176 | FEC |
| 20010572 | 20004530 | 1.56 | null | Adjuvant (A) | null | 2013-04-14 | FEC | null | null | 20037176 | FEC |
| 20010573 | 20126816 | 1.59 | 62.1 | Adjuvant (A) | 2017-04-12 | 2017-05-06 | FEC 60 or 75 | N | N | 20037187 | FEC |
| 20010574 | 20004531 | 1.68 | null | Adjuvant (A) | 2014-11-07 | 2014-12-05 | FEC 100 | N | N | 20037188 | FEC |
| 20010575 | 20004532 | null | null | 1 | 2013-04-04 | 2013-04-04 | FEC 60 or 75 | null | null | 20037189 | FEC |
| 20010576 | 20004532 | 1.66 | 100.5 | Not known (9) | 2015-01-29 | 2015-02-26 | FEC 60 or 75 | N | N | 20037189 | FEC |
| 20010577 | 20004532 | 1.72 | 80 | Adjuvant (A) | 2013-04-24 | 2013-04-24 | FEC 60 or 75 | N | N | 20037189 | FEC |
| 20010578 | 20004533 | 1.59 | 79.7 | Adjuvant (A) | 2013-07-14 | 2013-07-14 | FEC 60 or 75 | null | null | 20037213 | FEC |
| 20010579 | 20004533 | 1.65 | 58.4 | null | 2014-09-28 | 2014-09-29 | FEC 100 | N | null | 20037213 | FEC |
| 20010580 | 20106436 | 1.55 | 52.2 | Curative (C) | 2017-06-18 | 2017-08-03 | FEC 100 | N | N | 20037219 | FEC |
| 20010581 | 20106436 | 1.51 | 64.2 | Adjuvant (A) | 2014-12-03 | 2014-12-17 | FEC 100 | N | N | 20037219 | FEC |
| 20010582 | 20106436 | 1.59 | null | Adjuvant (A) | 2014-04-20 | 2014-05-08 | FEC 60 or 75 | N | N | 20037219 | FEC |
| 20010583 | 20106436 | 1.6 | 87.7 | Adjuvant (A) | 2013-10-22 | 2013-11-01 | FEC | N | N | 20037219 | FEC |
| 20010584 | 20106436 | null | 74.7 | Adjuvant (A) | 2014-01-10 | 2014-01-25 | FEC 100 | N | N | 20037219 | FEC |
| 20010585 | 20106436 | 1.6 | null | Adjuvant (A) | 2016-10-18 | 2016-10-18 | FEC 100 | Y | N | 20037219 | FEC |
| 20010586 | 20106436 | 1.64 | 72.1 | Adjuvant (A) | 2015-03-29 | 2015-04-24 | FEC | N | N | 20037219 | FEC |
| 20010587 | 20106436 | 1.77 | 75.7 | Adjuvant (A) | 2014-12-26 | 2014-12-27 | FEC 100 | 02 | null | 20037219 | FEC |
| 20010588 | 20106436 | 1.61 | 65.5 | Adjuvant (A) | 2013-12-23 | 2014-01-15 | FEC 100 | N | N | 20037219 | FEC |
| 20010589 | 20106436 | 1.64 | null | Adjuvant (A) | 2014-04-06 | 2014-04-06 | FEC 60 or 75 | 02 | null | 20037219 | FEC |
| 20010591 | 20004535 | 1.6 | 80.9 | Adjuvant (A) | 2017-07-10 | 2017-08-06 | FEC 60 or 75 | N | N | 20037251 | FEC |
| 20010592 | 20004536 | 1.55 | 114 | Palliative (P) | null | 2014-02-24 | FEC 100 | N | N | 20037252 | FEC |
| 20010593 | 20066862 | null | null | Adjuvant (A) | null | 2017-11-18 | FEC | 99 | N | 20037253 | FEC |
| 20010594 | 20066862 | 1.67 | null | Curative (C) | 2016-10-21 | 2016-10-22 | FEC 60 or 75 | null | null | 20037253 | FEC |
| 20010595 | 20004537 | 1.61 | 60 | Adjuvant (A) | 2016-04-23 | 2016-04-25 | FEC 100 | 02 | N | 20037268 | FEC |
| 20010596 | 20066863 | 1.6 | 57 | Neo-adjuvant (N) | 2015-04-21 | 2015-05-10 | FEC 100 | N | N | 20037271 | FEC |
| 20010597 | 20106438 | 1.64 | 74 | Neo-adjuvant (N) | 2016-06-20 | 2016-06-21 | FEC 100 | N | N | 20037274 | FEC |
| 20010598 | 20106438 | 1.52 | null | Adjuvant (A) | 2013-12-15 | 2013-12-29 | FEC 60 or 75 | N | N | 20037274 | FEC |
| 20010599 | 20106438 | 1.78 | 74.7 | Adjuvant (A) | 2016-05-02 | 2016-05-23 | FEC 60 or 75 | N | N | 20037274 | FEC |
| 20010600 | 20004538 | 1.61 | null | Not known (9) | null | 2013-06-19 | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | N | N | 20037278 | FEC |
| 20010601 | 20004538 | 1.55 | 51.6 | Adjuvant (A) | 2015-04-13 | 2015-04-28 | FEC 60 or 75 | N | N | 20037278 | FEC |
| 20010602 | 20004539 | 1.71 | 70.1 | Adjuvant (A) | 2015-01-07 | 2015-01-24 | FEC 100 | N | N | 20037282 | FEC |
| 20010603 | 20004539 | 1.57 | 98 | Not known (9) | 2017-08-03 | 2017-08-17 | FEC 100 | N | N | 20037282 | FEC |
| 20010604 | 20004539 | 1.62 | 77.5 | Adjuvant (A) | 2014-05-08 | 2014-05-15 | FEC 60 or 75 | 02 | N | 20037282 | FEC |
| 20010605 | 20004540 | 1.56 | 46 | Neo-adjuvant (N) | null | 2018-02-09 | FEC 100 | null | N | 20037316 | FEC |
| 20010606 | 20004540 | 1.6 | 125 | Adjuvant (A) | 2015-05-10 | 2015-05-24 | FEC 100 | 02 | null | 20037316 | FEC |
| 20010607 | 20004541 | 1.72 | 74 | Adjuvant (A) | 2016-08-26 | 2016-09-12 | FEC | N | N | 20037324 | FEC |
| 20010608 | 20004542 | 1.6 | 59.1 | Adjuvant (A) | 2014-08-15 | 2014-08-30 | FEC | 02 | N | 20037325 | FEC |
| 20010609 | 20004542 | 1.65 | 83.8 | Adjuvant (A) | 2013-06-27 | 2013-07-09 | FEC 60 or 75 | N | N | 20037325 | FEC |
| 20010610 | 20004543 | 1.6 | null | Adjuvant (A) | 2016-08-28 | 2016-09-05 | FEC 100 | N | N | 20037332 | FEC |
| 20010611 | 20004543 | 1.73 | 63 | Adjuvant (A) | 2017-01-28 | 2017-02-19 | FEC | 02 | N | 20037332 | FEC |
| 20010612 | 20004543 | null | null | Adjuvant (A) | 2013-07-28 | 2013-08-02 | FEC 100 | N | null | 20037332 | FEC |
| 20010613 | 20004544 | 1.54 | 63 | Adjuvant (A) | 2013-10-29 | 2013-11-11 | FEC 60 or 75 | N | N | 20037344 | FEC |
| 20010614 | 20066869 | 1.6 | 120.3 | Adjuvant (A) | null | 2017-05-05 | FEC 100 | null | null | 20037347 | FEC |